Pharmaceutical companies want to eliminate PBMs since they save patients a lot of money.
Senate Bill Targets Prescription Drug Pricing Recently, a bipartisan group of senators proposed new drug pricing laws aimed at addressing the role of pharmacy benefit managers (PBMs). Over the years, pharmaceutical companies have portrayed PBMs as villains in the prescription supply chain, arguing that these intermediary agents inflate prices and stifle innovation. This narrative is […]
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) released its second interim report on pharmacy benefit managers (PBMs) on Tuesday, finding that large industry intermediaries have increased their numbers through vertical integration, industry dominance, and increased prices for specialty drugs. He said it has generated billions of dollars in revenue. This report specifically focuses on the business practices […]